<SEC-DOCUMENT>0000945621-16-000664-index.html : 20160713
<SEC-HEADER>0000945621-16-000664.hdr.sgml : 20160713
<ACCEPTANCE-DATETIME>20160713170631
ACCESSION NUMBER:		0000945621-16-000664
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160712
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20160713
DATE AS OF CHANGE:		20160713

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aviragen Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		161766091

	BUSINESS ADDRESS:	
		STREET 1:		2500 NORTHWINDS PARKWAY, SUITE 100
		CITY:			ALPHARETTA
		STATE:			2Q
		ZIP:			30009
		BUSINESS PHONE:		301-770-3099

	MAIL ADDRESS:	
		STREET 1:		2500 NORTHWINDS PARKWAY, SUITE 100
		CITY:			ALPHARETTA
		STATE:			2Q
		ZIP:			30009

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI  BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20020304
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aviragen8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: aviragen8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>exhibit991.htm
<DESCRIPTION>PRESS RELEASE DATED JULY 12, 2016.
<TEXT>
Document 2 - file: exhibit991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00001.jpg
<TEXT>
Document 3 - file: image00001.jpg

</DOCUMENT>
</SEC-DOCUMENT>